Insider · CIK 0001604019

Bonstein Sara

Reports to the SEC for 6 companies · THOUSAND OAKS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001604019

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	XLOXilio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2026-06-03	INSMINSMED IncS Sale	Chief Financial Officer	SSale	−2,404 sh	$102.27	−$246K	69,082
2026-05-13	INSMINSMED IncS Sale	Chief Financial Officer	SSale	−8,272 sh	$116.18	−$961K	71,486
2026-02-03	INSMINSMED IncS Sale	Chief Financial Officer	SSale	−748 sh	$156.34	−$117K	79,758
2026-01-08	INSMINSMED IncS Sale	Chief Financial Officer	SSale	−1,447 sh	$174.17	−$252K	80,506
2026-01-07	INSMINSMED IncS Sale	Chief Financial Officer	SSale	−1,678 sh	$175.07	−$294K	81,953
2026-01-06	INSMINSMED IncS Sale	Chief Financial Officer	SSale	−1,517 sh	$173.33	−$263K	83,631
2026-01-02	INSMINSMED IncA Award	Chief Financial Officer	AAward	+5,998 sh	—	—	79,503
2026-01-02	INSMINSMED IncA Award	Chief Financial Officer	AAward	+5,645 sh	—	—	85,148
2026-01-02	INSMINSMED Inc · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+31.3K sh	—	—	31,280
2025-10-07	SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2025-10-07	SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−19.8K sh	—	—	0
2025-10-07	SCPHscPharmaceuticals Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.3K sh	—	—	0
2025-07-21	INSMINSMED IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,443 sh	$26.46	+$91.1K	87,460
2025-07-21	INSMINSMED IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+11.5K sh	$28.88	+$331K	98,915
2025-07-21	INSMINSMED IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+17.1K sh	$34.03	+$582K	131,905
2025-07-21	INSMINSMED IncS Sale	Chief Financial Officer	SSale	−32.1K sh	$102.38	−$3.29M	99,815
2025-07-21	INSMINSMED Inc · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−17.1K sh	—	—	0
2025-07-21	INSMINSMED Inc · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,443 sh	—	—	8,580
2025-07-21	INSMINSMED Inc · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−11.5K sh	—	—	0
2025-07-21	INSMINSMED Inc · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−15.9K sh	—	—	47,670
2025-07-21	INSMINSMED IncS Sale	Chief Financial Officer	SSale	−26.3K sh	$103.03	−$2.71M	73,505
2025-07-21	INSMINSMED IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+15.9K sh	$29.13	+$463K	114,805
2025-07-07	INSMINSMED Inc · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−13.7K sh	—	—	12,023
2025-07-07	INSMINSMED Inc · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−4,362 sh	—	—	0
2025-07-07	INSMINSMED IncS Sale	Chief Financial Officer	SSale	−22.2K sh	$96.19	−$2.13M	84,017
2025-07-07	INSMINSMED IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+23.6K sh	$26.43	+$623K	128,064
2025-07-07	INSMINSMED IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+13.7K sh	$26.46	+$363K	141,781
2025-07-07	INSMINSMED Inc · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−6,244 sh	—	—	18,880
2025-07-07	INSMINSMED IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+6,244 sh	$19.74	+$123K	100,137
2025-07-07	INSMINSMED Inc · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−23.6K sh	—	—	15,710
2025-07-07	INSMINSMED IncS Sale	Chief Financial Officer	SSale	−35.6K sh	$95.66	−$3.4M	106,198
2025-07-07	INSMINSMED IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+4,362 sh	$24.70	+$108K	104,499
2025-06-23	INSMINSMED Inc · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−12.6K sh	—	—	25,124
2025-06-23	INSMINSMED Inc · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−35.3K sh	—	—	99,007
2025-06-23	INSMINSMED IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+12.6K sh	$19.74	+$249K	151,301
2025-06-23	INSMINSMED IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+35.3K sh	$18.95	+$668K	138,665
2025-06-23	INSMINSMED IncS Sale	Chief Financial Officer	SSale	−49.1K sh	$101.71	−$4.99M	102,197
2025-06-23	INSMINSMED IncS Sale	Chief Financial Officer	SSale	−8,661 sh	$102.15	−$885K	93,536
2025-06-11	XLOXilio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+31K sh	—	—	31,000
2025-06-10	INSMINSMED IncS Sale	Chief Financial Officer	SSale	−100 sh	$91.66	−$9,166	103,412
2025-06-10	INSMINSMED IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+24.2K sh	$18.95	+$458K	137,438
2025-06-10	INSMINSMED Inc · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−24.2K sh	—	—	134,260
2025-06-10	INSMINSMED IncS Sale	Chief Financial Officer	SSale	−6,328 sh	$90.93	−$575K	103,512
2025-06-10	INSMINSMED IncS Sale	Chief Financial Officer	SSale	−7,277 sh	$87.12	−$634K	153,901
2025-06-10	INSMINSMED IncS Sale	Chief Financial Officer	SSale	−7,310 sh	$88.29	−$645K	146,591
2025-06-10	INSMINSMED IncM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+23.7K sh	$17.07	+$405K	161,178
2025-06-10	INSMINSMED IncS Sale	Chief Financial Officer	SSale	−20.9K sh	$88.99	−$1.86M	125,665
2025-06-10	INSMINSMED IncS Sale	Chief Financial Officer	SSale	−15.8K sh	$89.85	−$1.42M	109,840
2025-06-10	INSMINSMED Inc · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−23.7K sh	—	—	35,610

Recent filings

Accepted (ET)
Jun 124
Bonstein Sara0001193125-26-269396
SEC(opens sec.gov)
Jun 54
Bonstein Sara0001604019-26-000010
SEC(opens sec.gov)
May 154
Bonstein Sara0001604019-26-000008
SEC(opens sec.gov)
Feb 44
Bonstein Sara0001604019-26-000006
SEC(opens sec.gov)
Jan 84
Bonstein Sara0001604019-26-000004
SEC(opens sec.gov)
Jan 64
Bonstein Sara0001604019-26-000002
SEC(opens sec.gov)
Oct 74
Bonstein Sara0001193125-25-233530
SEC(opens sec.gov)
Jul 234
Bonstein Sara0001628280-25-035755
SEC(opens sec.gov)

Companies

Address

C/O LATIGO BIOTHERAPEUTICS, INC. 1300 RANCHO CONEJO BLVD., SUITE 305

THOUSAND OAKS, CA, 91320